Biosimilars and Biobetters
Solving the Biosimilars Void in Europe
Creating a Sustainable Access Environment for the Future
Since the first biosimilar launch in biosimilars have become an important part of the European healthcare system
Digital Biomarkers in Neuroscience – Benefits for Clinical Development, Physicians, and Patients
Disorders of the CNS which include a wide range of psychiatric and neurological conditions such as Alzheimers disease schizophrenia and depression have a profound impact on individuals and their families
BIOLOGICS
RESHAPING PHARMACEUTICAL MARKET
The biotherapeutics market is booming Currently annual growth rate of biologics is double that of conventional pharma and is forecasted to grow rapidly Increase in incidence of chronic diseases like cancer diabetes autoimmune diseases genetic conditionsetc and acceptance of biotherapeutics because of their high efficacy and safety are some of the m...
INTEGRATIVE ASSOCIATIVE CLASSIFICATION FOR CANCER BIOMARKER DISCOVERY
Biomarkers or biological markers cover a wide range of substances that can be measured from body tissues cells blood or fluid For instance a cell expresses genes when they are required for biological processes and the measurement of gene expressions under different physiological conditions provide essential clues of gene functions Therefore bioma...
